-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on NOV, Raises Price Target to $14

Benzinga·10/30/2025 17:33:56
Listen to the news
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price target from $11 to $14.